Page results
-
This is information for women about medical management after an ultrasound diagnosis of a miscarriage.
-
This booklet explains what you can expect during recovery from your autologous stem cell transplant.
-
The TB network for north central London aims to reduce the capital’s high number of new cases and making it easier for patients to receive treatment.
-
We provide a specialist service for the assessment and treatment of sarcoidosis as part of the interstitial lung disease (ILD) service at UCLH. We provide holistic multidisciplinary care, with a weekly consultant-led outpatient clinic and clinical nurse specialist support.
-
We are an established service that has worked closely with thousands of people living with MS across North London and Hertfordshire.
-
We offer an expert service for complex pulmonary embolic disease (PED) and follow up for all cases diagnosed with this condition at UCLH.
-
We provide a comprehensive service from early diagnosis to advanced treatments for severe COPD. We have a strong multidisciplinary team (MDT) including doctors, specialist nurses, physiotherapists, physiologists and psychologists, which enables us to provide holistic, personalised care to each of our patients.
-
Patient information for patients undergoing Image Rehearsal Therapy (IRT).
-
Oropharyngeal cancer is a type of cancer that affects the part of the throat at the back of the mouth.
-
Advice for University College London Hospital patients who have experienced hair loss.
File results
-
FOI/2023/0542 - Pulmonary rehabilitation (PR)
-
FOI/2023/0550 - Varicose veins referrals, treatment and wait time
-
FOI/2023/0553 - Maternity complaints by ethnicity
-
FOI/2023/0559 - Patients admitted to hospital with dental distress
-
FOI/2023/0560 - Digital maternity training platform
-
FOI/2023/0561 - Birthrate Plus
-
FOI/2023/0563 - Treatment for Haemophilia B and Von Willebrand disease
-
FOI/2023/0565 - Rare diseases - diagnosis/ treatment for Fabry/ Gaucher/ Pompe
-
FOI/2023/0566 - Structure chart for IM &T, Business Intelligence, Informatics
-
FOI/2023/0569 - Treatment for Ruxolitinib